Balyasny Asset Management LLC Gsk PLC Transaction History

Balyasny Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$42.05 - $47.77 $32.4 Million - $36.9 Million	-771,680 Reduced 68.27%	358,680 $15.6 Million
Q1 2022 May 16, 2022	BUY	$40.23 - $47.74 $34.4 Million - $40.9 Million	855,693 Added 311.54%	1,130,360 $49.2 Million
Q4 2021 Feb 14, 2022	SELL	$38.88 - $45.31 $9.21 Million - $10.7 Million	-236,788 Reduced 46.3%	274,667 $12.1 Million
Q3 2021 Nov 15, 2021	BUY	$38.79 - $43.16 $19.8 Million - $22.1 Million	511,455 New	511,455 $19.5 Million
Q2 2020 Aug 14, 2020	SELL	$37.87 - $43.58 $4.14 Million - $4.76 Million	-109,285 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$32.47 - $48.83 $21.9 Million - $32.9 Million	-674,306 Reduced 86.05%	109,285 $4.14 Million
Q4 2017 Feb 14, 2018	BUY	$35.34 - $41.9 $20 Million - $23.7 Million	565,528 Added 259.34%	783,591 $27.8 Million
Q3 2017 Nov 14, 2017	BUY	$39.44 - $41.55 $8.6 Million - $9.06 Million	218,063	218,063 $8.85 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.